2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$3.18+$0.14 (+4.57%)
Price as of Jun 23, 2026 7:55 PM EDT- $661.8MMarket Cap
- 40.74%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$3.18+$0.14 (+4.57%)
Earnings Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 21 |
Momentum Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -15.45% | ||
12-Month Momentum | 60.34% | ||
3-Month Risk Adjusted Momentum | -69.46% | ||
12-Month Risk Adjusted Momentum | 65.23% |
True Yield
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 2.79% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |